TMCi Accelerator for Cancer Therapeutics (ACT)

5 Saved

Claim Profile

Report

Reach out to TMCi Accelerator for Cancer Therapeutics (ACT)

About TMCi Accelerator for Cancer Therapeutics (ACT)

Investor type

Incubator & Accelerator

Application periodicity

In batches

Themes

biomarkers

metabolomics

in vitro diagnostics

metabolites

medicine

drugs

mRNA

+29

See all

Funding Stages

1. Idea or Patent 2. Prototype 3. Early Revenue

Countries of investment

USA

Who we are

Texas Medical Center (TMC) is the world's largest medical complex. Since opening in 1945, TMC has been pioneering patient care, research, education and prevention. Today, TMC comprises 54 leading member institutions, including 21 renowned hospitals; three public health organizations; two universities; three medical schools; six nursing programs; two pharmacy schools; a dental school; eight academic and research institutions; and 13 support organizations. Our vision: TMC is at the forefront of advancing life sciences. As home to brightest minds in medicine, TMC nurtures cross-institutional collaboration, creativity and innovation. Because together, we can push the limits of what's possible. Our world-renowned patient care, research and education institutions have one common goal: transform the future of medicine. As the largest concentration of scientists anywhere, we're harnessing our collective knowledge, talent and technology to lead the next generation of innovation.

Funding Requirements

We accelerate texas-based biotech entrepreneurs and researchers developing cancer therapeutics and oncology innovations at pre-ind to early clinical stages

Value add

Access to tailored mentorship and entrepreneurs-in-residence, project gap analysis and development planning, Texas Medical Center and Gulf Coast Consortia research networks, computational chemistry resources for drug discovery and lead optimization, grant-writing support, and relationship-building opportunities with corporate partners and industry experts.